Tag Archives: Goodlatte

CNBC Commentary: Hedge funds, ‘reverse trolls’ crushing biopharma innovation

Vote No on HR 9

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to perform the long and costly research and development for cures and therapies to combat devastating diseases such as cancer, HIV and Alzheimer’s. Unfortunately, the system that helps protect these innovations is being abused by outside interests. BIO and others have called upon Congress to fix these problems as part of a greater patent reform debate. Today one more voice joined Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Big Oil Asks Congress to Do What the Courts Denied

shutterstock_2103563

“This contention is meritless.” Doesn’t “withstand scrutiny.” “Ignores salient facts.” That was the judgment of the U.S. Court of Appeals for the DC Circuit on Monroe Energy and PBF Energy’s challenge to the 2013 Renewable Fuel Standard. The companies asked the Court to vacate the entire RFS for 2013, claiming the blendwall makes it impossible for them to comply with the RFS and EPA did not use its waiver authority to reduce biofuel use. “Neither Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,

House Judiciary Committee’s Patent Reform Bill is in Need of Reform, Says BIO

PRESS RELEASE WASHINGTON, D.C. (Friday, April 15, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the America Invents Act, H.R. 1249, which passed the House Committee on the Judiciary yesterday:   “BIO has consistently praised House Judiciary Committee Chairman Lamar Smith (R-TX) for his introduction of a comprehensive patent reform bill similar to the bill adopted by the U.S. Senate earlier this month by a nearly unanimous vote.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,